Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.66 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 6/20 | 0.58 |
| ▸ | NPC1 | O15118 | 4/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 8/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | CASP3 | P42574 | 1/20 | 0.51 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.51 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.51 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.51 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzaldehyde SCHEMBL28191631 | 0.85 | CYP2A6 (0.83) | CYP2A6CYP2A13RAB9ANPC1HPGD | |
| SCHEMBL15901558 | 0.85 | ALDH1A1 (0.60) | CYP2A6KMT2AALDH1A1MAPK1KDM4E | |
| SCHEMBL31674561 | 0.85 | ALDH1A1 (0.60) | CYP2A6KMT2AALDH1A1MAPK1KDM4E | |
| SCHEMBL24851242 | 0.85 | RAB9A (0.69) | RAB9ANPC1HPGDKMT2AMEN1 | |
| SCHEMBL20012341 | 0.83 | ALDH1A1 (0.68) | RAB9ANPC1HPGDKMT2AMEN1 | |
| Biphenyl SCHEMBL11048367 | 0.82 | CYP2A6 (0.76) | CYP2A6CYP2A13RAB9ANPC1HPGD | |
| Methyl Alcohol SCHEMBL11054490 | 0.81 | CYP2A6 (0.91) | CYP2A6CYP2A13RAB9ANPC1HPGD | |
| SCHEMBL61517 | 0.81 | CYP2A6 (1.00) | CYP2A6CYP2A13RAB9ANPC1KMT2A | |
| SCHEMBL9789927 | 0.80 | CYP2A6 (0.73) | CYP2A6CYP2A13RAB9ANPC1HPGD | |
| SCHEMBL7693616 | 0.80 | CYP2A6 (0.73) | CYP2A6CYP2A13RAB9ANPC1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114213419-B | Fluorescent probe with fluorescence imaging and I-type photodynamic/photothermal cancer cell killing activities as well as preparation method and application thereof | 内蒙古大学 | 2022-11-15 | — | — | CN | claimed |
| CN-114213419-A | Fluorescent probe with fluorescence imaging and I-type photodynamic/photothermal cancer cell killing activities as well as preparation method and application thereof | 内蒙古大学 | 2022-03-22 | — | — | CN | claimed |
| US-20230181744-A1 | COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES | FUDAN UNIVERSITY (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230181744-A1 | COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES | FUDAN UNIVERSITY (CN) | 2023-06-15 | — | — | US | disclosed |
| CN-114213419-B | Fluorescent probe with fluorescence imaging and I-type photodynamic/photothermal cancer cell killing activities as well as preparation method and application thereof | 内蒙古大学 | 2022-11-15 | — | — | CN | disclosed |
| CN-114213419-A | Fluorescent probe with fluorescence imaging and I-type photodynamic/photothermal cancer cell killing activities as well as preparation method and application thereof | 内蒙古大学 | 2022-03-22 | — | — | CN | disclosed |
| WO-2021213518-A1 | COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES | 复旦大学 (CN) | 2021-10-28 | — | — | WO | disclosed |
| CN-104877665-B | Luminescent material having aggregation-induced emission, method of making and application thereof | 香港科技大学深圳研究院 | 2017-01-11 | — | — | CN | disclosed |
| CN-104877665-A | Luminescent material having aggregation-induced emission, method of making and application thereof | UNIV HONG KONG SCIENCE & TECHN | 2015-09-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230181744-A1 | COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES | MAP1LC3B, MAP1LC3A, SQSTM1 | CYP2A6 224/4885CYP2A13 171/4885RAB9A 803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.